US 11752181
Compositions and methods of treating Huntington's disease
granted A61KA61K35/76A61K48/00
Quick answer
US patent 11752181 (Compositions and methods of treating Huntington's disease) held by VOYAGER THERAPEUTICS, INC. expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VOYAGER THERAPEUTICS, INC.
- Grant date
- Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K35/76, A61K48/00, A61P, A61P25/14